Skip to main content
Premium Trial:

Request an Annual Quote

People in the News

MedMira: Sam Ratnam

MedMira has appointed Sam Ratnam as its director of scientific and regulatory affairs. Ratnam is a clinical professor at Memorial University of Newfoundland and adjunct professor at McGill University in Montreal. His prior experience includes work as director of Newfoundland's public health laboratory, advisor to the Public Health Agency of Canada's National Microbiology Laboratory, and temporary advisor to the World Health Organization.

Trinity Biotech: Aris Kekedjian

Trinity Biotech has appointed Aris Kekedjian its CEO, effective Oct. 3. He succeeds Trinity cofounder Ronan O'Caoimh, who will remain on the company's board. Kekedjian also is becoming the firm's chairman. He has more than 30 years of global business leadership and was most recently president and CEO of Icahn Enterprises, senior advisor to ECN Capital, and independent director at companies including Xerox, Finserv Acquisition, and XPO Logistics. He also spent 30 years at General Electric and was most recently its chief investment officer and global head of business development.

Roche: Matt Sause

Roche announced that Matt Sause, currently the president and CEO of Roche Diagnostics' North America Region, would become CEO of Roche Diagnostics, effective Jan. 1, 2023. Sause will take over from Thomas Schinecker, current CEO of Roche Diagnostics who will become Roche's CEO on March 15. Sause previously served as lifecycle leader for Tecentriq Lung and Head and Neck Cancers at Roche subsidiary Genentech and has been in a variety of commercial general management and global product leadership roles at Roche since he joined the company in 2002. 


Fulgent Genetics: John Bolger

John Bolger has resigned from the board of directors at Fulgent Genetics. Effective as of September 24, 2022, Fulgent said Bolger's decision to resign was not due to any disagreement with the company on any matter relating to the company's operations, policies, or practices. Bolger served as chair of the board's audit committee and was also a member of the compensation committee and the nominating and corporate governance committee.

Lasker Award: Yuk Ming Dennis Lo

Yuk Ming Dennis Lo has won the 2022 Lasker-DeBakey Clinical Medical Research Award for discovering cell-free fetal DNA in maternal blood and developing noninvasive prenatal testing for Down syndrome. He is a professor of medicine and chemical pathology at the Chinese University of Hong Kong.

Progentec Diagnostics: Marc Jones

Marc Jones has joined Progentec Diagnostic's board of directors. He is also on the board of PathFinder Health and was most recently COO and CFO of Binx Health. Previously, Jones was interim Executive Chairman of Ivenix. Progentec is developing diagnostics and digital technologies for the management of autoimmune diseases.

Next Gen Diagnostics: Daniel Rhoads

Daniel Rhoads has joined the scientific advisory board of Next Gen Diagnostics. He is currently in charge of Cleveland Clinic's bacteriology operations. Next Gen Diagnostics was founded by members of the Sanger Institute and offers pathogen bioinformatics products to enable the high-throughput clinical use of whole-genome sequencing. It also offers sequencing services to detect pathogen transmission in hospitals.

OncoCyte: James Liu

OncoCyte has appointed James Liu the firm's controller and principal accounting officer, effective Sept. 20. He was previously OncoCyte's manager of Securities and Exchange Commission reporting and compliance. Since July 2022, he was the company's interim controller. Between November 2020 and July 2021, Liu was the accounting manager of Acacia Research.

Roche: Julie Brown

Roche announced that Julie Brown will be stepping down as a member of the board of directors, effective immediately, after accepting the CFO role at pharmaceutical company GSK, starting in May. Brown was elected to the board in March 2016 and has been the chairwoman of the audit committee since then. Patrick Frost will be the interim chair of the committee until the general meeting in March 2023. 

Brown currently serves as chief operating and financial officer at fashion firm Burberry. She was previously group CFO at medical technology company Smith and Nephew. Brown also held multiple roles at AstraZeneca, including interim group CFO and VP of group finance, regional commercial VP of Latin America, and VP of corporate strategy.

Next Gen Diagnostics: Romney Humphries

Romney Humphries has joined the scientific advisory board of Next Gen Diagnostics. Humphries is the director of clinical microbiology at Vanderbilt University Medical Center and was a member of the scientific advisory board at Specific Diagnostics prior to it being sold to BioMérieux in May. Founded by members of the Sanger Institute, Next Gen Diagnostics offers pathogen bioinformatics products to enable the high-throughput clinical use of whole-genome sequencing. It also offers sequencing services for the detection of pathogen transmission in hospitals.